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Interference with the transmission of sensory signals along visual and auditory pathways
has been implicated in the pathogenesis of hallucinations. The relay centres for vision (the
lateral geniculate nucleus) and hearing (the medial geniculate nucleus) appear to be sus-
ceptible to the uptake of circulating mercury. We therefore investigated the distribution of
mercury in cells of both these geniculate nuclei.
Materials and methods
Paraffin-embedded tissue sections containing the lateral geniculate nucleus were obtained
from 50 adults (age range 20–104 years) who at autopsy had a variety of clinicopathological
conditions, including neurological and psychiatric disorders. The medial geniculate nucleus
was present in seven sections. Sections were stained for mercury using autometallography.
Laser ablation-inductively coupled plasma-mass spectrometry was used to confirm the
presence of mercury.
Results
Ten people had mercury in cells of the lateral geniculate nucleus, and in the medial genicu-
late nucleus of three of these. Medical diagnoses in these individuals were: none (3), Parkin-
son disease (3), and one each of depression, bipolar disorder, multiple sclerosis, and
mercury self-injection. Mercury was distributed in different groups of geniculate capillary
endothelial cells, neurons, oligodendrocytes, and astrocytes. Mass spectrometry confirmed
the presence of mercury.
Conclusion
Mercury is present in different combinations of cell types in the lateral and medial geniculate
nuclei in a proportion of people from varied backgrounds. This raises the possibility that mer-
cury-induced impairment of the function of the geniculate nuclei could play a part in the
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genesis of visual and auditory hallucinations. Although these findings do not provide a direct
link between mercury in geniculate cells and hallucinations, they suggest that further investi-
gations into the possibility of toxicant-induced hallucinations are warranted.
Introduction
Visual and auditory hallucinations, perceptions that occur in the absence of corresponding
sensory stimuli, can arise from a wide range of drug-induced, medical and psychiatric condi-
tions, as well as in the general population [1]. It has been proposed that hallucinations appear
because of interference with the visual or auditory pathways, followed by defective information
processing [2] (Fig 1). The thalamic lateral geniculate nucleus (LGN) is the main relay centre
in the visual pathway, and the nearby medial geniculate nucleus (MGL) in the auditory path-
way. These geniculate nuclei are therefore candidate sites for damage that could result in over-
activity of the primary visual and auditory cortices. Attempts to find histopathological changes
Fig 1. The defective information processing hypothesis for the origin of visual hallucinations. Normal LGN. Visual
signals from the retina are filtered and reorganised by the LGN before transmission to the primary visual cortex (PVC).
Other afferent neurons also synapse with neurons in the PVC. Damaged LGN. Neuronal transmission from the retina
to the PVC is impaired after damage (red) to the LGN. Other afferent neurons to the PVC compensate by increasing
their activity, stimulating the PCV to generate visual hallucinations.
https://doi.org/10.1371/journal.pone.0231870.g001
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in the LGN in conditions where hallucinations are common, such as schizophrenia, have so
far been unsuccessful [3,4], though magnetic resonance imaging studies suggest the LGN can
be smaller than normal in Parkinson disease [5] and multiple sclerosis [6], disorders in which
hallucinations have been described [7,8].
One human study, using neutron activation analysis on fresh brain tissue from 17 randomly
selected autopsies, showed that, while average mercury levels were highest in the cerebellum
(0.28 μg/g), the next highest levels were in the geniculate bodies (0.20 μg/g), with lower levels
in other regions of the brain such as the pons and the calcarine cortex [9]. Several animal
experiments suggest mercury enters the geniculate nuclei preferentially [10–16]. In monkeys
exposed to methylmercury, average tissue levels of mercury were higher in the LGN than in
other regions of the brain [10]. Monkeys exposed to methylmercury had ultrastructural
changes in neurons of the LGN [11]. Damage to LGN neurons has been described in a mer-
cury-exposed dog [12], and bismuth has been seen to accumulate in the MGN of mice [13]. In
rats exposed to various forms of mercury, mercury was visible in the LGN and MGN, though
usually only at higher levels of exposure [14–16].
Mercury in neurons can cause axonal atrophy without producing light microscopic signs of
damage in neuronal cell bodies [17]. This implies that mercury could be an agent that interferes
with the function of geniculate neurons, given that histological changes in the cell bodies of
geniculate neurons are rarely present in humans [3,4]. We therefore investigated whether any
people from varied clinicopathological backgrounds had mercury in cells of their LGN or MGN.
Methods
Ethics statement
This study (X14-029) was approved by the Human Research Committee, Sydney Local Health
District (Royal Prince Alfred Hospital Zone), and by the Office of the New South Wales Coro-
ner. The institutional review board waived the need for written informed consent from rela-
tives to use the tissues removed for standard diagnostic purposes at coronial autopsy from
these deceased individuals for scientific purposes since this was a de-identified retrospective
study of archived paraffin-embedded tissue.
Cases
Cases selected for study were 48 adults who had coronial autopsies performed at the Glebe
Department of Forensic Medicine, Sydney, in whom (1) archived paraffin blocks of the LGN
and adjacent hippocampus were available, and (2) the number of locus coeruleus neurons that
contained mercury (a potential marker of previous mercury exposure) had been measured in a
previous study [18]. Two adults who were donors to the Multiple Sclerosis Research Australia
Brain Bank at the Brain and Mind Centre, Sydney, were also included. The 50 individuals
comprised 26 males (age range 20–98 years, mean age 47 years) and 24 females (age range 29–
104 years, mean age 66 years) (S1 Table). Pre-mortem medical conditions were: none
(N = 12), Parkinson disease (N = 9), schizophrenia (N = 7), Alzheimer disease (N = 5), depres-
sion (N = 5), bipolar disorder (N = 3), Huntington disease (N = 2), multiple sclerosis (N = 2),
and one each of anorexia nervosa, Lewy body disease, myotonic dystrophy, progressive supra-
nuclear palsy, and mercury self-injection. Mercury levels in the individual who injected him-
self with metallic mercury were greatly raised in organs such as the kidney and liver, but only
slightly higher than normal in the cerebrum [19], indicating that relatively few brain cells took
up the circulating mercury. Causes of death were suicide (N = 14), cardiovascular disease
(N = 10), infection (N = 8), trauma (N = 6), drowning (N = 4), drug overdose (N = 2), undeter-
mined (N = 4), and one each of burns and undernutrition (S1 Table).
PLOS ONE Mercury in geniculate nuclei
PLOS ONE | https://doi.org/10.1371/journal.pone.0231870 April 22, 2020 3 / 16
Autometallography (AMG)
Paraffin blocks taken from the LGN and adjacent hippocampus were sectioned at 7 μm. In
seven blocks the medial geniculate nucleus was also present. Sections were stained for inor-
ganic mercury bound to sulphide or selenide using silver nitrate autometallography (AMG),
which represents the presence of mercury as black grains [20]. AMG is a sensitive photo-
graphic technique that can detect as few as 10 mercury sulphide/selenide molecules in a cell
[21]. Briefly, sections were placed in physical developer containing 50% gum arabic, citrate
buffer, hydroquinone, and silver nitrate at 26˚C for 80 min in the dark then washed in 5%
sodium thiosulphate to remove unbound silver. Sections were counterstained with mer-
cury-free hematoxylin or Luxol fast blue and viewed with bright-field microscopy. Other
sections were stained with hematoxylin and eosin to assess general pathology, and hematox-
ylin alone to act as a control for the AMG/hematoxylin. In two mercury-positive LGN indi-
viduals, sections were immunostained after AMG/hematoxylin with glial fibrillary acidic
protein antibody to see if mercury was present in astrocytes; briefly, sections were treated
with hydrogen peroxide to block endogenous peroxidase activity, antigen retrieved by heat-
ing, non-specific antigen blocked with horse serum, rabbit anti-human glial fibrillary acidic
protein polyclonal antibody (Dako M0761) applied at a 1:2000 dilution, and diaminobenzi-
dine tetrahydrochloride used for visualisation. Each staining run included a control section
of mouse spinal cord where motor neuron cell bodies contained mercury following an
intraperitoneal injection of mercuric chloride [17]. AMG is a histochemical amplification
technique, so it cannot be used to quantitate the amount of mercury in individual cells.
However, because the timing of the reactions was kept the same between runs, different cat-
egories of staining between samples could be estimated: the category of AMG staining in
groups of cells was graded as absent if no cells stained, moderate if fewer than 50% of cells
stained, and marked if more than 50% of cells stained.
Laser ablation-inductively coupled plasma-mass spectrometry
(LA-ICP-MS)
In addition to mercury, AMG detects inorganic silver and bismuth [20,22]. To confirm that
AMG in this tissue was due to mercury, a 7 μm paraffin section from an AMG mercury-pos-
itive case was subjected to LA-ICP-MS to qualitatively determine the presence of mercury,
silver, bismuth, and phosphorus (the latter to assess cell density), as well as for aluminium,
cadmium, chromium, gold, iron, lead, and nickel. Analyses were carried out on an
NWR193 excimer laser (Kenelec Scientific) hyphenated to an Agilent Technologies 7700
ICP-MS fitted with ‘s’ lenses for enhanced sensitivity, with argon used as the carrier gas.
LA-ICP-MS conditions were optimised on NIST 612 Trace Element in Glass CRM and the
sample was ablated with a 50 μm spot size and a scan speed of 100 μm/s at a frequency of 20
Hz. The data were collated into a single image file using in-house developed software and
visualised using FIJI. The limit of detection for mercury using LA-ICP-MS has been calcu-
lated to be 0.08 μg/g [23].
Mercury content of the locus coeruleus
The human locus coeruleus in the rostral pons appears to be particularly susceptible to take up
and retain circulating mercury [18] and has therefore been suggested to be an indicator of pre-
vious exposure to mercury [24]. The mercury content of the geniculate nuclei was therefore
compared with that of paired locus coeruleus sections from the same individuals.
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Results
Autometallography
AMG-detected mercury was present in the LGN or MGN of ten individuals in various combi-
nations of endothelial cells, neurons, oligodendrocytes (Table 1) as well as in astrocytes.
Endothelial cells. In nine of the mercury-affected geniculate nuclei, mercury was present
in the endothelial cells of capillaries (Table 1). Capillaries containing mercury were situated
within, and in some people also immediately adjacent to, the geniculate nuclei (Fig 2). Mer-
cury was present either diffusely or focally in the cytoplasm of endothelial cells, or as focal col-
lections adjacent to endothelial cell nuclei (Figs 2 and 3). There was no consistent relationship
between the amount of endothelial mercury and the mercury content of neurons or oligoden-
drocytes: widespread capillary mercury could be associated with little or no neuronal and oli-
godendrocyte mercury, and widespread neuronal mercury with little or no endothelial
mercury (Table 1 and Figs 2 and 3).
Neurons. Mercury-containing LGN neurons were present in all magnocellular, parvocellu-
lar, and koniocellular layers. Parvocellular neurons appeared on average to have a greater mercury
density than magnocellular neurons (Fig 3). In five people the great majority of LGN neurons
contained mercury (Table 1). Mercury could be seen either as discrete small or medium-sized
deposits in the cytoplasm, or as small grains on a background of lipofuscin (Fig 3).
Oligodendrocytes. Oligodendrocytes were recognised by their characteristic small,
round, densely hematoxylin-stained nucleus, with an artefactually shrunken cytoplasm. In six
people mercury was readily detected in many (but not all) oligodendrocytes (Table 1). Mer-
cury appeared as dense black AMG staining in the oligodendrocyte cytoplasm, adjacent to the
nucleus (Figs 2, 3 and 4).
Astrocytes. Combined AMG and GFAP staining in two people showed a variation in
astrocyte morphology and mercury content, even though both individuals had similar wide-
spread mercury uptake in LGN capillaries, neurons and oligodendrocytes. In G1, mercury
deposits were seen in a few normal-sized perivascular astrocytes, and in the perivascular glia
limitans; in G2, on the other hand, numerous hypertrophic, predominantly perivascular, astro-
cytes contained mercury (Fig 4).
The distribution of mercury in endothelial cells, neurons, and oligodendrocytes in the three
MGN was similar to that of the paired LGN from the same person. No cells in the adjacent
Table 1. The distribution of mercury in cells of the lateral geniculate nucleus of ten mercury-positive individuals.
ID no. Age group Gender Diagnosis Cells Other
END NEU OLG
G1 76–80 Female Parkinson disease + ++ +
G2 36–40 Male None + ++ +
G3 71–75 Female Parkinson disease + ++ +
G4 36–40 Female Bipolar disorder ++ ++ +
G5 71–75 Female Multiple sclerosis ++ + - MGN
G6 61–65 Male Depression - ++ -
G7 36–40 Male None ++ - + MGN
G8 61–65 Male Parkinson disease + + +
G9 96–100 Male None + + -
G10 21–25 Male Mercury injection + - - MGN
END: endothelial cell, MGN: same mercury distribution in medial geniculate nucleus, NEU: neuron, OLG: oligodendrocyte. Category of mercury distribution:–absent,
+ moderate, ++ marked.
https://doi.org/10.1371/journal.pone.0231870.t001
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Fig 2. Mercury in geniculate blood vessels. (A) Low power view showing the anatomy of the LGN and MGN (within dashed lines). The boxes B, C
and D are enlarged in following images. AMG/Luxol fast blue. (B) Most capillaries in the LGN contain mercury (eg, closed arrow), as do capillaries
close to the LGN in the adjacent white matter (eg, open arrow). A nearby larger blood vessel (BV) in the white matter between the geniculate nuclei
does not contain mercury. AMG/Luxol fast blue. (C) In the LGN, mercury is seen in endothelial cells of longitudinal (closed arrow) and transverse
(arrowhead) capillary profiles. Two magnocellular neurons (circled) contain light particulate mercury, while one neuron (dashed circle) is mercury-
free. AMG/Luxol fast blue. (D) In the MGN, mercury is seen in endothelial cells of longitudinal (closed arrow) and transverse (arrowhead) capillary
profiles, similar to the LGN. Two magnocellular neurons (circled) contain moderate particulate mercury. AMG/Luxol fast blue. (E) Scattered LGN
capillaries contain focal endothelial mercury (arrow and box). In this part of the LGN, neurons (eg, circled) do not contain mercury. AMG/
hematoxylin. (F) Mercury is clustered around LGN endothelial cell nuclei (boxes 1 and 2). Nearby neurons (eg, circled) stain heavily for mercury, as
do some oligodendrocytes (arrowheads). AMG/hematoxylin. G: identify number.
https://doi.org/10.1371/journal.pone.0231870.g002
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hippocampus, or tail of the caudate nucleus, stained for mercury in any individual. Hematoxy-
lin-only-stained sections showed no black deposits in any cells. Large amounts of lipofuscin
were present in the geniculate neurons of all 50 individuals.
Comparison of LGN and locus coeruleus mercury
All ten individuals with mercury-positive geniculate nuclei had more than 50% of locus coeru-
leus neurons that contained mercury. Of the 40 individuals in whom no geniculate mercury
was found, numbers of mercury-containing locus coeruleus neurons were large (>50% of neu-
rons) in 13, medium (11–50% of neurons) in 11, small (1–10% of neurons) in 3, and none in
13 people (S1 Table).
Fig 3. Mercury in geniculate neurons and oligodendrocytes. (A) Dense particulate mercury is seen in LGN parvocellular neurons (upper right, high power
view in box 1). Magnocellular neurons (lower left, high power view in box 2) have less dense mercury on average than parvocellular neurons. A few small cells
(eg, arrowhead) in the koniocellular layer contain mercury. AMG/hematoxylin. (B) Dense mercury deposits are seen in the shrunken cytoplasm of some
oligodendrocyte cell bodies (eg, in boxes 1 and 2). Most neurons (eg, circled) contain mercury. One capillary (arrow) is mercury-free. AMG/Luxol fast blue. (C)
Fine particulate mercury is seen in all LGN neurons (eg, box) and diffuse faint mercury staining is seen in the neuropil. Longitudinal (arrow) and transverse
(arrowhead) capillary profiles show mercury in endothelial cells. AMG/hematoxylin. (D) Moderate scattered particulate mercury is seen, on a background of
light yellow-brown lipofuscin, in many LGN neurons (eg, circled, and box). A capillary (arrow) has dense endothelial mercury. AMG/hematoxylin. G: identify
number.
https://doi.org/10.1371/journal.pone.0231870.g003
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Fig 4. Mercury in geniculate astrocytes. (A) A brown-immunostained perivascular astrocyte in the LGN contains
particulate mercury in its cytoplasm and processes (box 1). Particulate mercury (arrowhead) is present in the
perivascular glia limitans, next to the artefactually-expanded perivascular space (�) of a small blood vessel (BV).
Mercury is present adjacent to the nucleus of some oligodendrocytes (eg, box 2) and in the cytoplasm of neurons (eg,
box 3). AMG/hematoxylin/GFAP. (B) Numerous perivascular brown-immunostained hyperplastic astrocytes in this
LGN contain black mercury deposits (eg, arrow and box C, enlarged in 4C). Most neuronal (eg, circled) and some
oligodendrocyte (arrowhead) cell bodies contain mercury. AMG/hematoxylin/GFAP. (C) Enlarged view of box C in
(B) shows mercury in the cytoplasm of a hypertrophic astrocyte (open arrow) with processes extending to surrounding
mercury-containing neurons (closed arrows) and oligodendrocytes, one with cytoplasmic mercury (circled) and one
without (dash circled). AMG/hematoxylin/GFAP. G: identify number.
https://doi.org/10.1371/journal.pone.0231870.g004
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LA-ICP-MS
AMG staining of the LGN in G1 was confirmed to be due to the presence of mercury on
LA-ICP-MS, which showed no significant uptake of the other two metals that can be stained
with AMG, silver and bismuth (Fig 5). No aluminium, cadmium, chromium, gold, iron, lead,
or nickel was seen in the LGN.
Discussion
Key findings of this study are that a proportion of people from a wide background of clinico-
pathological conditions had mercury in cells of their LGN and MGN. The distribution of mer-
cury-containing cell types varied between individuals. These results raise the possibility that
exposure to mercury, with preferential uptake in the geniculate nuclei, followed by inhibition
of geniculate neuronal output and subsequent overactivity of the primary visual and auditory
cortices, could be one factor underlying visual and auditory hallucinations.
Mercury kinetics and metabolism within human cells is complex and only partially under-
stood [25]. In the brain, methylmercury is slowly changed into inorganic mercury, the proxi-
mate toxic species. The effect of mercury within cells is likely to be a balance between the
ingress of mercury from environmental exposure, the protective mechanisms within cells
against mercury toxicity (such as binding to metallothioneins and selenium, and sequestration
in lysosomes), and methods used to clear mercury from cells [26]. Most hallucinations are
transitory, which may be the case because of this dynamic nature of toxic metal metabolism
within cells. Mercury may be mostly toxic to cells while free and reactive in the cytoplasm
Fig 5. Laser ablation-inductively coupled plasma-mass spectrometry of an AMG-positive lateral geniculate nucleus (LGN, outlined). (A) Phosphorus
scanning shows the phosphorus-rich cell layers of the LGN, compared to the uniformly dense phosphorus content of the adjacent tissue. (B) Mercury scanning
shows a marked uptake of mercury in cells throughout most of the LGN. No significant amount of silver (C) or bismuth (D) is present in the LGN.
Scale = counts per seconds (proportional to abundance).
https://doi.org/10.1371/journal.pone.0231870.g005
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early after exposure, when it is able to affect membranous organelles, and before it is
ensconced within lysosomes or cleared from cells, either by a cellular pathway involving astro-
cytes [26], back through the blood-brain barrier [27], or via the glymphatic pathway that clears
mercury from the interstitial fluid [28,29] (Fig 6).
Capillaries within, and immediately adjacent to, the geniculate nuclei, appeared to take up
circulating mercury avidly, and this is probably the reason these geniculate cells were predis-
posed to take up mercury. Increased uptake of mercury by these endothelial cells may relate to
the density or nature of mercury transporters in these cells [30–32]. Of note, all individuals
with geniculate mercury also had many locus coeruleus neurons containing mercury. The
locus coeruleus plays a role in maintaining the blood-brain barrier [33], so if the locus coeru-
leus neurons that contained damaging mercury were those supplying microvessels in the
geniculate nuclei, circulating mercury could enter the geniculate nuclei readily via leaky
capillaries.
Mercury within neurons varied from fine or dense particulate accumulations in the cell
body, to scattered deposits within lipofuscin. Ultrastructural studies of neuronal mercury accu-
mulation in experimental animals indicate that most mercury accumulates in lysosomes, some
localises to membranous organelles such as mitochondria, the endoplasmic reticulum, the
Golgi apparatus, and nuclear membranes, while some remains free in the cytoplasm [34–36].
The different patterns of mercury deposition seen in our geniculate neurons probably repre-
sent differences in the form of mercury exposed to (eg, vapor, organic, or inorganic), the fre-
quency of exposure, and the time elapsed since last exposure. (1) The pattern of dense
particulate neuronal mercury, probably in lysosomes (Fig 3B), is likely to represent continual
or repeated exposures to mercury. Lysosomes play an important part in many cell processes
[37], some of which could be affected by large amounts of mercury. A potential clinical
Fig 6. Potential pathways of mercury entry and exit in cells of the geniculate nuclei. (A) Circulating mercury (red dots) enters brain capillaries and passes
into endothelial cells. Mercury passes through the perivascular space and is taken up by the endfeet of perivascular astrocytes. (B) Mercury collects in the cell
bodies of perivascular astrocytes and is passed through gap junctions into neurons and oligodendrocytes. (C) Within neurons and oligodendrocytes, mercury is
located within lysosomes, attached to mitochondria, endoplasmic reticulum, Golgi apparatus, and nuclear membranes, and free in the cytoplasm. (D) Mercury
is removed from neurons through gap junctions into adjacent astrocytes, which transfer the mercury to venules. (E) Mercury enters the lumen of venules and is
removed from the brain. Some mercury enters the perivenular space. (F) Some capillary mercury enters the interstitial fluid directly. (G) Some forms or
mercury pass through the cell membrane directly into the interstitial space. (H) Interstitial mercury enters the perivenular space via the glymphatic pathway
and exits the brain through the cerebrospinal fluid.
https://doi.org/10.1371/journal.pone.0231870.g006
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correlation of this pattern of mercury deposition comes from individual G2, a fisherman who
drowned at sea, who probably had a diet rich in fish, with large predatory fish having a high
mercury content [38]. (2) The pattern of fine particulate neuronal mercury, as well as diffuse
mercury in the neuropil (Fig 3C), is likely to result from recent exposure to mercury. Individ-
ual G4 died a few days after suffering extensive burns from ignited kerosene, which can con-
tain mercury [39]. (3) Small scattered mercury particles on a background of lipofuscin (Fig
3D) probably indicate previous remote exposure to mercury, with partial removal of mercury
from the cell body.
Our findings of mercury adjacent to the nuclei of oligodendrocytes recapitulates findings in
the cerebral cortex from this man who injected himself with metallic mercury [40], as well as
ultrastructural studies of rats exposed to mercury which showed mercury binding to oligoden-
drocyte nuclear membranes [34] and lysosomes [36]. Mercury in oligodendrocytes could affect
myelin metabolism and axonal conductance, which has the potential to slow nerve impulses
from the geniculate nuclei to their respective primary cortices.
Astrocytes are known depots for metals, and play a major part in the uptake, storage and
release of toxic metals [26]. In two of our samples, in which LGN neurons and capillaries had
similar amounts of mercury, astrocyte morphology differed markedly. This probably repre-
sents differences in the time between mercury exposure and tissue sampling, with the hyper-
plastic astrocytes reacting to recent exposure. Astrocytes are likely to play a role in both the
accumulation and release and mercury [26], but since we could sample the geniculate nuclei at
only one time point, we were unable to determine in which direction (from blood vessel to
astrocyte, or from astrocyte to blood vessel) mercury in astrocytes was travelling.
Evidence from epidemiological and clinical studies supports the possibility that environ-
mental toxicants such as mercury play a part in visual and auditory hallucinations. Exposure
to environmental pollution, including heavy metals, has long been considered a possible risk
factor for psychiatric disorders such as schizophrenia that are frequently accompanied by hal-
lucinations [41–43]. Visual and auditory hallucinations often occur together, giving rise to the
concept of ‘bound’ hallucinations [7]. The closely adjacent LGN and MGN nuclei in our study
shared the same pattern of mercury accumulation which could explain why visual and audi-
tory hallucinations so often co-exist. An alternative explanation, that the same pathology is
affecting the far-apart primary visual and auditory cortices, seems less likely. Hallucinations
are not uncommon in conditions in which we found geniculate mercury, namely Parkinson
disease [7], depression [44], bipolar disorder [45] and multiple sclerosis [8]. Three of our mer-
cury-affected geniculate individuals had no known major medical conditions, but visual hallu-
cinations have been recorded in 7% of a general community [46].
Mercury exposure alone is not enough to result in mercury accumulation in the geniculate
nuclei. For example, the individual who injected himself with metallic mercury, and who had
large deposits of mercury in his body [40], had only minor geniculate endothelial mercury
deposits, and none in his geniculate neurons or oligodendrocytes. Furthermore, while all indi-
viduals with geniculate mercury also had many locus coeruleus neurons containing mercury, a
probable marker for previous mercury exposure [18], several people had locus coeruleus neu-
rons containing mercury but no mercury in their geniculate nuclei. A possible explanation for
the latter situation is that mercury had been cleared over time from their geniculate nuclei, but
was retained in the locus coeruleus indefinitely because of its content of metal-binding neuro-
melanin [47,48].
It has long been noted that geniculate neurons contain a large amount of the ‘wear-and-
tear’ pigment, lipofuscin [47,49–51], and this was the case in all our samples. The origin of
lipofuscin remains obscure, but the large amount of lipofuscin that accumulates on aging in
the geniculate neurons suggests these geniculate neurons are repeatedly exposed to toxicants
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that need to be processed by lysosomes [47]. Other neurons that have been shown to have a
predilection to accumulate mercury, such as spinal [52] and cortical [53] motor neurons, also
usually have large lipofuscin deposits. Lipofuscin may therefore turn out to be a marker of tox-
icant exposure to neurons. Despite the LGN showing marked lipofuscin accumulation during
aging, LGN neurons appear to be resistant to age-related neuronal loss [51]. This may be
because LGN neurons have efficient mechanisms of clearing toxicants such as mercury from
their cell bodies, leaving behind lipofuscin as a signature of previous damage to organelles
such as mitochondria [51].
People with schizophrenia have frequent visual and auditory hallucinations [1], but we
found no mercury in the geniculate nuclei of the seven people with schizophrenia that we stud-
ied. This may be because mercury exposure occurred early in life and damaged the geniculate
neurons, with the mercury being cleared from these neurons before death (a ‘hit and run’ situa-
tion). On the other hand, another toxicant currently not detectable at the cellular level could be
causing geniculate neuronal damage. Further cell-based elemental analyses, such as synchrotron
X-ray fluorescence microscopy, performed on geniculate cells could shed light on this issue,
though this technique requires cryofixed sections of brain tissue for reliable results [54].
Neurons from the retina play only a small part in afferent stimuli to the LGN [55], and far
from being only a visual relay station, multiple functions have now been ascribed to the LGN
[55–57]. One possibility that has been raised is that damage to the LGN, by hindering light sig-
nals entering the suprachiasmatic nucleus, could lead to changes in circadian rhythms that
cause sleep disturbances [58]. In addition, accumulation of bismuth has been described in the
suprachiasmatic nuclei of mice [59], and bismuth affects the same neuronal types as mercury
[13], but it is not known if mercury accumulates in the human suprachiasmatic nucleus. Sleep
disturbances and hallucinations often co-exist in psychiatric conditions [60], so further investi-
gations of toxicants in both the LGN and suprachiasmatic nucleus may be of value.
This study has several limitations. (1) We had access only to major clinical diagnoses of our
study population, so we do not know whether any specific individual had experienced visual
or auditory hallucinations. Ideally, imaging of metals within the geniculate nuclei, together
with functional analyses of geniculate nuclei activity, would be undertaken at a time when hal-
lucinations were being experienced, but this is not technically possible at present. (2) We do
not know how and when our study population were exposed to mercury. In a future study,
people who have frequent hallucinations could be asked to keep a detailed diary of dietary
intake (especially of mercury-containing fish), bruxism or dental manipulations what might
increase mercury uptake from silver amalgam dental restorations, and occupational activities
that could expose them to mercury [38], to see if any mercury-related associations with the
onset of hallucinations could be found. This could be expanded to population studies to see if
the frequency of hallucinations increases in people exposed to mercury from small-scale gold
mining [61], living near coal-fired power stations [61], volcanic activity [62], or wildfires [63–
65]. (3) We did not have access to complete medical histories of these individuals, and so are
not able to determine whether any medications taken by them could have altered mercury tox-
icokinetics. (4) Only a few MGN were available for study. This is because routine neuropatho-
logical sampling of the hippocampus usually includes the LGN, but seldom the more medially-
situated MGN. Future prospective sampling of the MGN would be needed to comprehensively
study toxicants in the MGN. (5) Autometallography can detect only the inorganic form of
mercury, but since this is the proximate toxic form of the metal [25] for clinical purposes this
is likely to be the most important form to detect. (6) Comparisons of our autometallography
results with previous measurements of mercury in the geniculate nuclei and other parts of the
brain are difficult, since we looked at mercury within individual cells, while the previous report
of human geniculate mercury used bulk chemical analyses of fresh tissue [9]. We did not have
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access to fresh tissue to measure mercury content in the whole brain. (7) We were not able to
quantitative the amount of mercury in individual cells using these methods. One way to do
this is to use synchrotron x-ray fluorescence microanalysis, but this requires fresh frozen sec-
tions of tissue [54], which were not available to us. This issue warrants further study, since
other metal toxicants such as lead have been suggested to be triggers for hallucinations [66].
In conclusion, this study indicates that a proportion of people from a mixed clinicopatho-
logical background have mercury in cells of their lateral and medial geniculate nuclei. This
raises the possibility that this neurotoxicant affects the functions of these nuclei, which could
precipitate the onset of visual and auditory hallucinations, because of subsequent overactivity
of other afferents to the primary visual and auditory cortices. Although these findings do not
provide a direct link between mercury in the geniculate nuclei and hallucinations, they suggest
that further investigations into toxicant-induced hallucinations are warranted.
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